Cadila Healthcare
Buy on Cadila Healthcare with target of Rs 370
We initiate coverage on Cadila Healthcare (CDH) with BUY and a Mar17 TP of `370.
Cadila gets US FDA nod to sell generic anti-viral drug
The drugs will be manufactured in Ahmedabad
Zydus acquires gastro therapy ‘Actibile’ from Albert David
Strengthens its presence in the gastroenterology segment Zydus Healthcare, a wholly-owned subsidiary of Cadila Healthcare has entered into a definitive agreement to acquire ‘Actibile’ from Albert David. The brand
9 stocks that remained in news today: Lupin, Excel Industries and more
Zydus Healthcare, a subsidiary of Cadila Healthcare, has acquired gastrointestinal brand 'Actibile' from drug firm Albert David for an undisclosed amount.
Cadila Q3 net up 38 per cent at Rs 390 cr
Total income of the company rose to Rs 2,428 crore for the third quarter
FIPB clears 5 FDI proposals worth Rs 6,050 cr; Cadila Healthcare gets nod
Government today approved five foreign investment proposals involving an inflow of Rs 6,050 crore including a Rs 5,000-crore plan of Cadila Healthcare for fresh equity infusion.
USFDA alleges Cadila’s 2 plants for violating CGMP regulations
Torn notebook with record of 'deficiencies', plastic bags filled with shreds of paperwork, failure to adequately investigate and address consumer complaints, are some of the major norm violations found by the USFDA at Cadila
Cadila Healthcare receives warning letter from US FDA
The letters were received for its two facilities in Gujarat Cadila Healthcare has received a warning letter from the US Food and Drug Administration (US FDA) for its two facilities in Gujarat. “The company has received
Top 8 stocks that made news today: Cadila Healthcare, Petronet LNG and more
Gas importer Petronet LNG will buy liquefied natural gas (LNG) from Qatar's Rasgas at virtually half the original cost, the government said in a statement on Thursday.
Cadila Healthcare Ltd shares surge nearly 3% as Q2 net profit zooms 40%
Cadila Healthcare Ltd shares surged on Friday after the company posted 40.56 per cent jump in consolidated net profit to Rs 390.91 for the second quarter ended on September 30, 2015-16.
